Skip to main content

and
  1. Article

    Open Access

    Enhanced plant-derived vesicles for nucleotide delivery for cancer therapy

    Small RNAs (microRNAs [miRNAs] or small interfering RNAs [siRNAs]) are effective tools for cancer therapy, but many of the existing carriers for their delivery are limited by low bioavailability, insufficient ...

    Sara Corvigno, Yuan Liu, Emine Bayraktar, Elaine Stur in npj Precision Oncology (2024)

  2. Article

    Open Access

    In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy

    In this study, we investigated the metabolic alterations associated with clinical response to chemotherapy in patients with ovarian cancer. Pre- and post-neoadjuvant chemotherapy (NACT) tissues from patients w...

    Sara Corvigno, Sunil Badal, Meredith L. Spradlin, Michael Keating in npj Precision Oncology (2023)

  3. Article

    Open Access

    Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L

    Antiangiogenic treatment targeting the vascular endothelial growth factor (VEGF) pathway is a powerful tool to combat tumor growth and progression; however, drug resistance frequently emerges. We identify CD5L...

    Christopher J. LaFargue, Paola Amero, Kyunghee Noh in Nature Communications (2023)

  4. Article

    Open Access

    Targeting CCR2+ macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer

    Tumor-associated macrophages (TAMs) are known to contribute to adaptive resistance to anti-vascular endothelial growth factor (VEGF) antibody (AVA) therapy in ovarian cancer. BET (bromodomain and extra-termina...

    Yutuan Wu, Nicholas B. Jennings, Yunjie Sun in Journal of Cancer Research and Clinical On… (2022)

  5. No Access

    Article

    The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis

    Paxillin (PXN), a key component of the focal adhesion complex, has been associated with cancer progression, but the underlying mechanisms are poorly understood. The purpose of this study was to elucidate mecha...

    Kyunghee Noh, Duc-Hiep Bach, Hyun-** Choi, Mark S. Kim, Sherry Y. Wu in Oncogene (2021)

  6. Article

    Open Access

    Potential biomarkers of ductal carcinoma in situ progression

    Ductal carcinoma in situ is a non-obligate precursor of invasive breast carcinoma and presents a potential risk of over or undertreatment. Finding molecular biomarkers of disease progression could allow for mo...

    Raquel Spinassé Dettogni, Elaine Stur, Ana Carolina Laus in BMC Cancer (2020)

  7. No Access

    Article

    Analysis of genome instability in breast cancer

    Breast cancer is a heterogeneous disease, previously associated with genomic instability. Our aim was to analyze microsatellite markers in order to determine patterns and levels of instability, as well as poss...

    Eldamária de Vargas Wolfgramm, Lyvia Neves Rebello Alves in Molecular Biology Reports (2013)

  8. No Access

    Article

    Promoter hypermethylation in primary squamous cell carcinoma of the oral cavity and oropharynx: a study of a Brazilian cohort

    Epigenetic silencing of cancer-related genes plays an important role in oral/oropharyngeal squamous cell carcinoma (OSCC). We evaluated promoter hypermethylation of 4 cancer-related genes in OSCCs of a Brazili...

    Melissa de Freitas Cordeiro-Silva, Elaine Stur in Molecular Biology Reports (2012)